product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
JMJD2A (C37E5) Rabbit mAb
catalog :
5328
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
C37E5
reactivity :
human, mouse, rat
application :
western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation
more info or order :
Cell Signaling Technology product webpage
citations: 3
Published Application/Species/Sample/DilutionReference
  • western blot; mouse; fig 1d
Pedersen M, Agger K, Laugesen A, Johansen J, Cloos P, Christensen J, et al. The demethylase JMJD2C localizes to H3K4me3-positive transcription start sites and is dispensable for embryonic development. Mol Cell Biol. 2014;34:1031-45 pubmed publisher
Zhou J, Wang F, Xu C, Zhou Z, Zhang W. The histone demethylase JMJD2A regulates the expression of BDNF and mediates neuropathic pain in mice. Exp Cell Res. 2017;361:155-162 pubmed publisher
Li L, Xue A, Li B, Shen Y, Li Y, Luo C, et al. JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI. Breast Cancer Res. 2014;16:R56 pubmed publisher
product information
SKU :
5328S
Product-Name :
JMJD2A (C37E5) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Mk
Applications :
Immunofluorescence (Immunocytochemistry)
Product-Category :
Chromatin Regulation / Nuclear Function
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
150
Host :
Rabbit
Target :
JMJD2A
Primary-Protein :
JMJD2A
Alt-Names :
JHDM3A,JMJD2,JMJD2A,JmjC domain-containing histone demethylation protein 3A,Jumonji domain-containing protein 2A,KDM4A,KIAA0677,Lysine-specific demethylase 4A,jumonji C domain-containing histone demethylase 3A,jumonji domain containing 2,jumonji domain containing 2A,lysine (K)-specific demethylase 4A
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.